Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current concepts in multiple sclerosis: Part II.

Linda J Hanson1, William A Cafruny

  • 1USD School of Medicine, Vermillion, SD, USA.

South Dakota Journal of Medicine
|November 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus.

Journal of virology·2007
Same author

Porcine reproductive and respiratory syndrome virus (PRRSV) infection spreads by cell-to-cell transfer in cultured MARC-145 cells, is dependent on an intact cytoskeleton, and is suppressed by drug-targeting of cell permissiveness to virus infection.

Virology journal·2006
Same author

Polyclonal hypergammaglobulinemia and formation of hydrophobic immune complexes in porcine reproductive and respiratory syndrome virus-infected and uninfected pigs.

Viral immunology·2005
Same author

Lactate dehydrogenase-elevating virus induces apoptosis in cultured macrophages and in spinal cords of C58 mice coincident with onset of murine amyotrophic lateral sclerosis.

Virus research·2004
Same author

Hydrophobic IgG-containing immune complexes in the plasma of autoimmune MRL/lpr mice, lactate dehydrogenase-elevating virus-infected mice, and pigs: association with transforming growth factor-beta and pH-dependent amplification.

Viral immunology·2004
Same author

Glucocorticoid regulation of lactate dehydrogenase-elevating virus replication in macrophages.

Virus research·2003
Same journal

Idiopathic pure red cell aplasia: case report with review of literature.

South Dakota journal of medicine·2006
Same journal

Use of cold-adapted live attenuated influenza vaccine in pediatric patients.

South Dakota journal of medicine·2006
Same journal

Hope.

South Dakota journal of medicine·2006
Same journal

AMA and SDSMA: together, we are stronger.

South Dakota journal of medicine·2006
Same journal

Acute immune thrombocytopenic purpura in children and adolescents in South Dakota 1998-2004.

South Dakota journal of medicine·2006
Same journal

Medication-induced fever.

South Dakota journal of medicine·2006
See all related articles

Multiple sclerosis (MS) is an autoimmune disease potentially triggered by viral infections in genetically susceptible individuals. Research focuses on causes, genetic interactions, and future treatments like vaccination and refined immunomodulation.

Area of Science:

  • Neuroimmunology
  • Autoimmune Diseases
  • Epidemiology

Background:

  • Multiple sclerosis (MS) is a central nervous system autoimmune disorder affecting 0.1% of the US population.
  • Viral infections are suspected triggers in genetically susceptible individuals, leading to autoimmune attacks on nerve cells.
  • The disease course is variable, characterized by relapses and remissions.

Purpose of the Study:

  • To investigate the potential viral causes of multiple sclerosis.
  • To understand the interaction between host genes and immunopathogenic mechanisms in MS.
  • To explore future therapeutic strategies for MS.

Main Methods:

  • Review of current evidence on viral triggers and genetic susceptibility in MS.
  • Analysis of immunomodulating treatments like interferon-beta and intravenous immunoglobulins.

Related Experiment Videos

  • Exploration of ongoing research into MS pathogenesis.
  • Main Results:

    • Partial treatment success achieved with immunomodulating agents.
    • Ongoing research aims to elucidate viral etiologies and genetic factors.
    • Potential for future MS vaccines and improved immunomodulation therapies.

    Conclusions:

    • MS pathogenesis involves a complex interplay of viral triggers and host genetics.
    • Current treatments offer partial efficacy, highlighting the need for further research.
    • Future directions include preventative vaccination and advanced immunomodulatory therapies.